A Synthetic, Small, Sulfated Agent Is a Promising Inhibitor of Chlamydia spp. Infection in vivo

Chlamydia is the most frequently reported sexually transmitted bacteria causing 2.9 million infections annually in the United States. Diagnosis, treatment, and sequelae of chlamydial disease cost billions of dollars each year in the United States alone. Considering that a heparin sulfate-like cell s...

Full description

Bibliographic Details
Main Authors: Karen M. Gallegos, Christopher R. Taylor, Daniel J. Rabulinski, Rosalinda Del Toro, Danielle E. Girgis, Dapinder Jourha, Vaibhav Tiwari, Umesh R. Desai, Kyle H. Ramsey
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-01-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2018.03269/full